Salix Pharmaceuticals Inc (SLXP)
Quote as of 4:00 PM ET 03/18/2010
| Exchange: |
NASDAQ GS |
| Last: |
30.68 |
| Change: |
$.00 |
| Percent Change: |
.00 |
| Volume: |
667,008 |
Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract. The Company?s products include XIFAXAN, MOVIPREP, OSMOPREP, VISICOL, APRISO, METOZOLV, AZASAN, ANUSOL-HC, PROCTOCORT cream, PEPCID, Oral Suspension DIURIL and COLAZAL. The Company?s products under development include Rifaximin, Crofelemer, Balsalazide disodium tablet and Budesonide foam.
|
|
|